Remarkably, we observed that CysLT2R mRNA expression in non-stimulated (baseline expression) and in IL-4-stimulated mast cells show significantly higher levels in mast cells from AD patients as compared to cells from HVs (Fig. 5I). This evidence concerns the gene CYSLTR2 and Alzheimer disease.